IgGenix, Inc., a clinical-stage biotechnology company pioneering innovative treatments for immune-mediated diseases, today ...
From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...
7d
HealthShots on MSNFuture Perspectives and Challenges in Recombinant Antibody DevelopmentRecombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...
Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...
CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE) announced the four-year results from the pivotal HOPE-B study ...
Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.
Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...
Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III ...
By optimizing gene synthesis methods and adopting high-efficiency cloning technology and screening strategies, our researchers overcame many obstacles, ultimately creating a fully human antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results